NU 518 FINAL EXAM 2026/2027 | ADVANCED
PHARMACOLOGY | 100 VERIFIED Q&A |
DETAILED RATIONALES | NGN-ALIGNED |
PASS GUARANTEED – A+ GRADED
SECTION 1: ADVANCED PHARMACOKINETICS AND PHARMACODYNAMICS - Questions 1-10
Q1: Two-Compartment Model
The student is reviewing pharmacokinetic models. In a two-compartment model, which phase
represents the distribution of a drug from the central compartment to peripheral tissues?
A. Alpha phase
B. Beta phase
C. Gamma phase
D. Delta phase
Correct Answer: A
Rationale: In a two-compartment model, the alpha phase is the initial rapid decline in plasma drug
concentration due to distribution from the central compartment (blood and highly perfused organs)
to peripheral tissues (less perfused tissues). The beta phase represents elimination. [100% CORRECT]
Q2: Context-Sensitive Half-Time
The student is reviewing pharmacokinetics. What does context-sensitive half-time refer to?
A. The time for plasma concentration to decrease by 50% after stopping an infusion
B. The time to reach steady-state during a continuous infusion
C. The half-life after a single IV bolus
D. The time to peak effect after oral administration
Correct Answer: A
Rationale: Context-sensitive half-time is the time required for the plasma concentration to decrease
by 50% after stopping a continuous infusion. It depends on the duration of the infusion and the
drug's distribution and elimination characteristics. It is important for drugs like propofol and
remifentanil. [100% CORRECT]
Q3: Protein Binding Displacement
The student is reviewing drug interactions. A patient taking warfarin (99% protein-bound) is
administered a drug that displaces it from albumin. What is the expected effect?
,2
A. Increased free warfarin and increased bleeding risk
B. Decreased free warfarin and decreased bleeding risk
C. No change in free warfarin
D. Increased warfarin metabolism
Correct Answer: A
Rationale: Displacement of warfarin from albumin increases the free (unbound) fraction, which is
pharmacologically active. This can enhance the anticoagulant effect and increase bleeding risk.
However, the free drug may also be metabolized and eliminated faster, so the net effect can be
complex. [100% CORRECT]
Q4: Enzyme Induction Time Course
The student is reviewing drug interactions. How long does it typically take for enzyme induction to
reach maximum effect?
A. 1-2 days
B. 1-2 weeks
C. 4-6 weeks
D. 3 months
Correct Answer: B
Rationale: Enzyme induction typically takes 1-2 weeks to reach maximum effect because it requires
synthesis of new enzyme proteins. The effect resolves over a similar period after the inducer is
discontinued. [100% CORRECT]
Q5: Zero-Order Kinetics Implications
The student is reviewing elimination kinetics. Which statement is true for a drug following zero-
order kinetics?
A. A constant fraction of the drug is eliminated per unit time
B. A constant amount of the drug is eliminated per unit time
C. The elimination rate increases with concentration
D. The half-life is constant regardless of concentration
Correct Answer: B
Rationale: Zero-order kinetics means a constant amount of drug is eliminated per unit time,
regardless of plasma concentration. This occurs when metabolic enzymes are saturated. The half-life
is not constant; it increases with higher concentrations. [100% CORRECT]
Q6: Pharmacodynamic Antagonism
The student is reviewing pharmacodynamics. What is competitive antagonism?
A. The antagonist binds reversibly to the same receptor as the agonist, reducing the agonist's effect
B. The antagonist binds irreversibly to the receptor
,3
C. The antagonist binds to a different site and reduces the agonist's effect
D. The antagonist increases the agonist's effect
Correct Answer: A
Rationale: Competitive antagonism occurs when an antagonist binds reversibly to the same receptor
site as the agonist, competing for binding. The effect can be overcome by increasing the agonist
concentration. Noncompetitive antagonism cannot be overcome. [100% CORRECT]
Q7: Therapeutic Index Calculation
The student is reviewing drug safety. A drug has an ED50 of 10 mg and an LD50 of 100 mg. What is
the therapeutic index?
A. 0.1
B. 1
C. 10
D. 100
Correct Answer: C
Rationale: Therapeutic index (TI) = LD50 / ED50 = 100 mg / 10 mg = 10. A higher TI indicates a safer
drug. A TI of 10 is relatively safe. [100% CORRECT]
Q8: Enteral vs Parenteral
The student is reviewing routes of administration. Which route has the highest bioavailability?
A. Oral
B. Rectal
C. Subcutaneous
D. Intravenous
Correct Answer: D
Rationale: Intravenous administration has 100% bioavailability because the drug is placed directly
into the systemic circulation, bypassing absorption barriers. Oral, rectal, and subcutaneous routes
have lower bioavailability due to incomplete absorption and/or first-pass metabolism. [100%
CORRECT]
Q9: Active Tubular Secretion
The student is reviewing renal excretion. Which process involves the active transport of drugs from
the blood into the renal tubule?
A. Glomerular filtration
B. Active tubular secretion
C. Passive tubular reabsorption
D. Enterohepatic recirculation
, 4
Correct Answer: B
Rationale: Active tubular secretion is an energy-dependent process that transports drugs from the
peritubular capillaries into the renal tubule. It can be saturated and competed for by other drugs.
[100% CORRECT]
Q10: Pharmacogenomics - CYP2D6 Ultra-Rapid Metabolizer
The student is reviewing pharmacogenomics. A patient is a CYP2D6 ultra-rapid metabolizer. Which
drug's toxicity risk is increased?
A. Codeine
B. Warfarin
C. Metoprolol
D. Omeprazole
Correct Answer: A
Rationale: CYP2D6 ultra-rapid metabolizers convert codeine to morphine more rapidly, leading to
higher morphine levels and increased risk of toxicity, including respiratory depression. Codeine
should be avoided in these patients. [100% CORRECT]
SECTION 2: CARDIOVASCULAR PHARMACOLOGY - Questions 11-25
Q11: Sacubitril/Valsartan Mechanism
The student is reviewing heart failure medications. What is the mechanism of action of
sacubitril/valsartan?
A. Inhibits neprilysin and blocks angiotensin II receptors
B. Inhibits ACE and blocks calcium channels
C. Blocks beta receptors and inhibits neprilysin
D. Inhibits renin and blocks aldosterone receptors
Correct Answer: A
Rationale: Sacubitril/valsartan combines a neprilysin inhibitor (sacubitril) that increases natriuretic
peptides, and an angiotensin II receptor blocker (valsartan). It is used for heart failure with reduced
ejection fraction. [100% CORRECT]
Q12: Ivabradine Mechanism
The student is reviewing heart failure medications. What is the mechanism of action of ivabradine?
A. Inhibits the If current in the sinoatrial node
B. Blocks beta-1 receptors
C. Blocks calcium channels
D. Inhibits angiotensin II receptors